IPTLD® a Registered Trademark by Donato Perez Garcia
Paseo de los Heroes # 10999 - 607
Tijuana, B.C. 22010 México
Phone:
From US: 011-52-(664)-686-5473
From US: 011-52-(664)-635-1834
Email: drdonato3@iptldmd.com
Join us at:
Copyright © 1930 – 2010 Donato Perez Garcia
Why You should consider IPTLD for the treatment of your cancer?
Cancer care and chronic degenerative diseases treated with Insulin Potentiation Therapy + Targeted Low Dose IPTLD®
IPTLD® a Kinder and Gentler Chemotherapy
Get the facts
How can you call a treatment that is dangerous or dubious if you haven't even seen how it is administered and what results are obtained by patients?
And that's exactly what the critics of reputable institutions and other less reputable websites are doing. Their written reviews on Insulin Potentiation Therapy + Targeted Low Dose or IPTLD are based solely on what they read,imagine or assume. So all their warnings to patients about IPTLD are dubious,inaccurate and reflect their ignorance on new findings on cell biology and chemistry as well as their disrespect to reputable researchers from equally reputable research facilities from around the globe.
Isn't it convenient to simply discredit a medical procedure that doesn't fit your agenda?
Does a reputable restaurant critic writes his/her reviews just based on reading the menu from the distance.
I welcome constructive criticism specially after seeing the procedure otherwise it is not positive to engage in a fruitless discussion or exchange of reviews over the internet posted by the self proclaimed critics on a procedure they do not know.
You as a patient have the final decision , in any event with all my professional respect to you as a person it is your body part that will be removed from your body, you have the choice, IPTLD can help to preserve your breast, ovaries, prostate, etc.
Other common name(s): The originator (my grandfather), Dr. Donato Perez Garcia (1896-1971), gave the name to his method of treatment as: “cellular therapy to change the biophysic chemical constants of the blood”. His son Dr. Donato Perez Garcia Bellon(1930-2000) used the same name and he also referred as the “treatment” or Donatian therapy. In the mid 1980's, Dr. Steven G. Ayre gave the short name if insulin potentation terapy (IPT)
Scientific/medical name(s): fractionated low dose chemotherapy with insulin biologic response modification.
Description: fractionated low dose chemotherapy with insulin biologic response modification or insulin potentiation targeted low dose (IPTLD) refers to the use of insulin along with reduced doses of chemotherapy to treat cancer. Can also be used with specific FDA drugs/supplements to treat some chronic diseases.
Overview: mostly individual of its results since 1930 conform the evidence and there are published scientific studies available showing that this treatment is safe and effective in treating cancer in humans. IPTLD does not have serious side effects. The use of insulin is safe as reported in a recent article (May of 2007) in the New England Journal of Medicine, the most respected medical journal of the world. N Engl J Med. 2007 May 3; 256(18):1842-52. Long-term effect of diabetes and its treatment on cognitive function.
*Diabetes Control andComplications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group;Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P,Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J.
Conclusions: no evidence of substantial long-term declines in cognitive function was found in a large group of patients with type 1 diabetes who were carefully followed for an average of 18 years, despite relatively high rates of recurrent severe hypoglycemia. (clinicaltrials.gov number, NCT00360893.)copyright 2007 Massachusetts medical society. PMID: 17476010.
How is promoted for use?
IPTLD is promoted as a “kinder, gentler” approach to chemotherapy, with “reduced side effects from chemo drugs”. It purports to use 15-25 percent of the usual dose of cancer treatment medicines. The effect on the chemotherapy is potentiated by the use of insulin, which lowers the blood sugar, that insulin “opens up” the receptors on cancer cells so that chemotherapy can get in .There is scientific evidence (published articles in medical journals) that supports this claim (see references below).
What does it involve?
The patient presents in the morning of the treatment preferably in a fasting state for 4 to 6 hours(can drink mineral or spring water).Intravenous (iv) fluids are started, and the patient is given a dose of insulin based on his or her body weight. For people with cancer, reduced dose of chemotherapy drugs are given a few minutes later so that they reach the bloodstream after the insulin has started to lower the patient's blood sugar. This is called the “therapeutic moment”
At this point, the patient usually has some symptoms of low blood sugar (hypoglycemia) like increased body temperature, perspiration and increased heart rate. This symptoms does not endanger the life of the patient. If a physician is not experienced with this procedure, the symptoms can be severe, because people can respond to a standard dose of insulin quite differently. To end the therapeutic moment the patient receives 25cc of dextrose to rise to normal levels blood sugar with in 3-5 minutes. To restore to a normal blood sugar a drink of electrolytes and fructose is given to raise the blood sugar further. During this process the blood sugar is checked by fingerstick.
Between treatments, the patient may be given chemotherapy drugs that they are taken by mouth, and also get vitamins or other supplements. Treatment is usually given once a week, generally for 18 to 24 cycles.
Dr. Donato Perez Garcia uses only FDA approved drugs/supplements and does not use with the treatment other substances like DMSO or supplements that do not have a proven benefit. He is the most experienced physician in Mexico and worldwide doing IPT/IPTLDt . The doctors he has trained have learned the IPT procedure since 2001, the majority of doctors from attending one of his training workshops.
What is the history behind it?
Insulin was first isolated from pancreatic tissue in Canada and used as a treatment for diabetes in early 1920's in the early 1930's in Europe and in the USA , insulin was used to produce coma for short periods in patients with schizophrenia in an attempt to cure them.This type of treatment for schizophrenia was abandoned in the 1950's.
IPT was developed in Mexico by Dr. Donato Perez Garcia, Sr., around the same time insulin had begun to be used in schizophrenics. In fact at this early stage, patients with cancer had a more severe reaction to insulin, but never a coma or never one of this patienrts had a complication or death for using using insulin during 44 years of practice of the late Dr. Donato Perez Garcia (1896-1971).Dr. Perez used this technique to treat several types of cancer. His son Dr. Donato Perez Garcia Bellon (1930-2000), and his grandson Dr. Donato Perez Garcia (currently working in Tjuana , Baja California , Mexico- August 2007), have followed in his footsteps.
What is the evidence?
A published study that looked at IPT was done in Uruguay . It included 30 women with breast cancer that was resistant to mainstream therapies. Of this women 10 got insulin alone, 10 got methotrexate (a chemotherapy drug) alone and 10 received IPT using both drugs. After 8 weeks, the researchers reported that the women in the IPT group had reductions in tumor size than either of the other groups.
Are there any possible problems or complications?
Because people respond differently to similar chemo drugs and other prescription drugs including insulin a few people have allergic reactions some may notice a fast heartbeat, low blood pressure, itching, or rash; reactions that do not endanger life and can be safely reversed with the appropiate medication.
Dr. Donato Perez Garcia recommends that this procedure must be done only by an experienced physician trained on the basic principles of IPT.
Insulin potentiation therapy IPT/IPTLD to treat cancer during pregnancy is not recommended, in fact it is a contradiction.
Critics from different organizations and hospital who lack the information, experience and training in this treatment warn patients that: “insulin has not been approved by the FDA to lower blood sugar to abnormal levels. Even when used as prescribed, it can be dangerous in some”. The problem with this warning is that they do not know the procedure and their warning is inaccurate. If you decided to be treated with this treatment you need to seek an experienced physician like Donato Perez Garcia,MD. Also note that the use of insulin with my treatment is not to lower your blood sugar to abnormal levels usually blood sugar drops 10 to 25 point below the normal limit and there is no danger.
Relying on this type of treatment IPT/IPTLD and avoiding or delaying “standard medical care” for cancer, may produce a remission- partial or complete- on your cancer and avoid your body from surgical mutilations.
Additional Resources
All critics of this IPTLD treatment say: “despite supporters” claims that IPTLD has been well researched, scientific studies that show safety and effectiveness have not been published in available peer reviewed journals.
The fact is YES I have published articles in journals and presented my findings at reputable institutions (read the references below).
REFERENCES
Presentations
National Center for Complementary and Alternative Medicine. NIH Bethesda , Maryland . October 22-23,2007.(invited by Jeff Whit, MD.)
Ayre SG, Perez Garcia y Bellon D, Perez Garcia D, Hauser R.: “Patient summaries for the insulin potentaition therapy best case series” third reunion from cancer advisory panel for complementary and alternative medicine, national center for complementary and alternative medicine.NIH, Bethesda , Maryland . September 18,2000
Ayre SG, Perez Garcia y Bellon D, Perez Garcia D.: “Insulin Potentaition Therapy –Best case series approach”, NIH “Practice Outcomes Monitoring and Evaluation System (POMES) for integrated complementary and alternative medicine cancer practices” organized by: the national institutes of health's office of alternative medicine (OAM) and the national cancer institute (NCI). Bethesda , Maryland , August 4-6, 1997 .
General scientific articles
Insulin Potentiation Therapy: a new concept for management of chronic degenerative disease.(SGA,D Perez Garcia Bellon and D. Perez Garcia , Jr. medical hypotheses (20(2):199-210,1986)
Cancer
Preclinical safety and efficacy of insulin combined with irradiation. Jordan BF ,Beghein N.Crokart N et al. radiother Oncol 2006;81(1):112-7.
Insulin induced enhancement if antitumoral response to methotrexate in breast cacer patients.Lasavio-prosco E. Cucchi S, Vazqez J, Lasavio- Galante E, Golomar W, Gordon W, cncer chemotherapy and pharmacology. 2003 dec. 4 the very first publication of IPT clinical trial data, IPT very significantly improved clinical outcome of low dose of chemotherapy in patients with advance breast cancer.
The effect of insuline chemotherapeutic drug sensitivity in human esophageal and lung cancer cells. Jiao SC, Huang J, Sun Y, Lu SX. Zhonghua Yi Xue Za Zhi.2003 feb 10;83 (3):195-7 (article in Chinese) insulin significantly enhanced the killing effect of three chemotherapy drugs on esophageal and lung cancer cell lines.
Insulin chemotherapy and the mechanisms of malignancy: the design and the demise of cancer SGA, D.P. Garcia y Bellon , D.P.Garcia Jr. Medical Hypotheses (2000) 55(4) 330-334, 2000.
Hoist by one's own petard: the design and the demise of cancer (SGA, M.D.M Townsend letter for doctors and patients, October 1999, pages 94-96)
Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells. Alabaster O, Vonderhaar BK,ans Shafie SM, 1981, European journal of cancer and clinical Oncology 17(11):1223-1228.
Breast cancer
Insulin-induced enhancement of antitumoral response to methitrexate in breast cancer patients. Lasavia-Prisco E, Ccucchi S, Vazquez J, Lasalvia-Galante E, Gordon W, cancer chemother pharmacol.2003 Dec. 4 the very first publication of IPT trial data.
Primary breast conserving treatment for breast cancer using biologic response modification with insulin in combination with non-toxic low-dose chemotherapy. SGA .Poster presentation at the third annual comprehensive cancer management conference, Washington DC , June 2000.
Insulin shows promise as BRM in breast cancer regimens. (oncology news, 1991, 17(4):1, 7.)
Insulin plus low-dose CMF as neo-adjuvant chemo hormonal therapy for breast carcinoma. SGA, M.D, Donato Perez Garcia y Bellon, M.D, Donato Perez Garcia Jr. , M.D. the third international congress on neo.adjuvanat chemotherapy, Paris, France, February,6-9, 1991.
Neoadjuvant low-dose chemotherapy with insulin in breast carcinomas. (SGA,Donato Perez Garcia y Bellon, Donato Perez Garcia Jr., 1990, European journal of cancer 26(11-12):1262-3.)
Breast carcinoma treated by a regimen of low-dose chemotherapy and insulin: report of four cases and pharmacokinetic considerations.(SGA, Donato Perez Garcia y Bellon, Donato Perez Garcia Jr., poster abstract at 42 nd annual symposium on fundamental cancer center, university on Texas, Houston Texas, October 24-27, 1989)
Brain and central nervous system (CNS)
New approaches to the delivery of drugs to the brain. SGA, medical hypotheses 29:283-291,1989.
Blood-brain barrier passage of azidothymidine in rats: effects of insulin. SGA Brian Skaletski, and Aron D.Mosnaim. Res commun chem Pathol pharmacol.1989. Jan; 63(1):45-52.
Infectious diseases
Cellular permeability as a basis for radical treatment of syphilis: treatment for neurosyphilis and syphilis with insulin. (la permeabilidad cellular como base en el tratamiento radical de la sifilis: tratamiento de la neuro-sifilis y de la sifilis por insulina) by Dr. Donato Perez Garcia, revista medica militar, Vol. 1, no.2, May- June 1938, pages 1-77.
General public articles
Historical articles
Cellular therapy to change the biophysical-biochemical constants of the blood, or donatian therapy, Drs.Donato Perez Garcia (SGA MD, 1976, self-published report,41 pages). Based on his visit to Dr. Donato Perez Garcia 2.
Biological, biochemical, and physicochemical mechanisms of insulin that take the part on donatian therapy for treating cancer. (Mecanismos biológicos, bioquímicos y fisicoquímicos de la insulina que intervienen en la terapéutica donatiana para la curación de los enfermos de cáncer); by Donato Perez Garcia y Bellon.( Year unknown, unpublished paper.) 84 pages.
Insulin for everything (time magazine April 10,1944 , pages 43-44 – article about Donato 1.)
Donato Perez Garcia,MD Office Address Avenida Paseo de los Héroes No. 10999 Office 607
Zona Rió. Tijuana , Baja California 22010 MEXICO .
Phone:
(From US): 011-52-(664)-635-1834
(From US): 011-52-(664)-686-5473
Email: drdonato3@iptldmd.com
DISCLAIMER
I recognize that IPTLD is not for everyone or every condition, and that there are many alternatives to choose from. But IPTLD has saved and helped many lives, and is wonderful for those patients it works for. So we want to make this information about IPTLD available to anyone who wants it, to help them decide for themselves. Anecdotal case reports from sixty years of use suggest that Insulin Potentiation Therapy + Targeted Low Dose (IPTLD) might be effective in the treatment of cancer. There is, however, no collection of scientific data validating IPTLD as a treatment for malignant neoplastic diseases.